Jim Miller

FDA approvals renew the threat of competition from India and China.

A booming market may be stressing the service-delivery system.

An industry survey finds that pharma's outsourcing practices keep the industry from reaping the full benefits of outsourcing.

An industry survey finds that pharma's outsourcing practices keep the industry from reaping the full benefits of outsourcing.

While some companies float with the tide, others grab market share while business is good.

While some companies float with the tide, others grab market share while business is good.

Preferred models for clinical and nonclinical services move in opposite directions.

Preferred models for clinical and nonclinical services move in opposite directions.

Strong demand is straining service providers' project-management capabilities; Patheon receives a much-needed cash infusion.

Strong demand is straining service providers' project-management capabilities; Patheon receives a much-needed cash infusion.

As big pharmaceutical companies restructure and reevaluate the way they do business, contract research and manufacturing organizations could reap greater financial rewards.

As big pharmaceutical companies restructure and reevaluate the way they do business, contract research and manufacturing organizations could reap greater financial rewards.

Sixty deals were completed in 2006, with a total value of $2 billion.

Sixty deals were completed in 2006, with a total value of $2 billion.

The recent struggles of Cardinal Health's and Patheon's contract dose manufacturing businesses offer a lesson on good business practices.

The recent struggles of Cardinal Health's and Patheon's contract dose manufacturing businesses offer a lesson on good business practices.

The recent struggles of Cardinal Health's and Patheon's contract dose manufacturing businesses offer a lesson on good business practices.

The integrated services model is the "next big thing" in CMC and early development services.

The integrated services model is the "next big thing" in CMC and early development services.

Mid-size regional players have little chance for success in an industry increasingly dominated by large global players.

Mid-size regional players have little chance for success in an industry increasingly dominated by large global players.

More CMOs look to proprietary delivery technologies to enhance profitability.

More CMOs look to proprietary delivery technologies to enhance profitability.

More CMOs look to proprietary delivery technologies to enhance profitability.

Contract service providers should be concerned about the market perceptions of their performance.

Contract service providers should be concerned about the market perceptions of their performance.

The principal objective of the annual PharmSource–Pharmaceutical Technology outsourcing survey is to gauge overall business trends in the contract manufacturing and research businesses. This year's edition documents an industry that is in good health but facing a new set of dynamics.

China is on the rise as a center for pharmaceutical R&D, but companies are still getting their footing for operating in China and the services industry has some maturing to do.

China is on the rise as a center for pharmaceutical R&D, but companies are still getting their footing for operating in China and the services industry has some maturing to do.

The laboratory supplier landscape is undergoing a radical makeover.